Uterine sarcomas

International Journal of Gynecology and Obstetrics

Volumn 131, Issue , 2015, Pages S105-S110

  Prat, Jaime ^a   Mbatani, 'Nomonde ^b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ABDOMINAL HYSTERECTOMY; ADENOSARCOMA; ARTICLE; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CARCINOSARCOMA; CLINICAL FEATURE; CYTOREDUCTIVE SURGERY; ENDOMETRIAL STROMAL TUMOR; ENDOMETRIUM SARCOMA; FEMALE; FOLLOW UP; HUMAN; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; LEIOMYOSARCOMA; LYMPH NODE DISSECTION; MITOSIS RATE; MOLECULAR BIOLOGY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SALPINGOOOPHORECTOMY; TREATMENT RESPONSE; UTERUS SARCOMA; WHOLE BODY RADIATION; PATHOLOGY; SARCOMA; UTERINE NEOPLASMS;

FEMALE; HUMANS; NEOPLASM STAGING; SARCOMA; UTERINE NEOPLASMS;

EID: 84944069691     PISSN: 00207292     EISSN: 18793479     Source Type: Journal    
DOI: 10.1016/j.ijgo.2015.06.006     Document Type: Article

References (35)

1. F.J. Major, J.A. Blessing, S.G. Silverberg, C.P. Morrow, W.T. Creasman, J.L. Currie, and et al. Prognostic factors in early stage uterine sarcoma: a Gynecologic Oncology Group study Cancer 71 4 Suppl 1993 1702 1709
2. R.L. Giuntoli 2nd, D.S. Metzinger, C.S. DiMarco, S.S. Cha, J.A. Sloan, G.L. Keeney, and et al. Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy Gynecol Oncol 89 3 2003 460 469
3. E. Oliva, M.L. Carcangiu, S.G. Carinelli, P. Ip, T. Loening, T.A. Longacre, and et al. Mesenchymal tumours (Chapter 5: Tumours of the uterine corpus) R.J. Kurman, M.L. Carcangiu, C.S. Herrington, R.H. Young, WHO Classification of Tumours of Female Reproductive Organs 4th ed. 2014 IARC Lyon 135 147
4. J. Prat FIGO staging for uterine sarcomas Int J Gynecol Obstet 104 3 2009 177 178
5. O. Lavie, O. Barnett-Griness, S.A. Narod, and G. Rennert The risk of developing uterine sarcoma after tamoxifen use Int J Gynecol Cancer 18 2 2008 352 356
6. S.G. Silverberg, F.J. Major, J.A. Blessing, B. Fetter, F.B. Askin, S.Y. Liao, and et al. Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus. A Gynecologic Oncology Group pathologic study of 203 cases Int J Gynecol Pathol 9 1 1990 1 19
7. V.M. Abeler, O. Royne, S. Thoresen, H.E. Danielsen, J.M. Nesland, and G.B. Kristensen Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients Histopathology 54 3 2009 355 364
8. L. Chen, and B. Yang Immunohistochemical analysis of p16, p53, and Ki-67 expression in uterine smooth muscle tumors Int J Gynecol Pathol 27 3 2008 326 332
9. S.K. Ylisaukko-oja, M. Kiuru, H.J. Lehtonen, R. Lehtonen, E. Pukkala, J. Arola, and et al. Analysis of fumarate hydratase mutations in a population-based series of early onset uterine leiomyosarcoma patients Int J Cancer 119 2 2006 283 287
10. E. D'Angelo, L.G. Spagnoli, and J. Prat Comparative clinicopathologic and immunohistochemical analysis of uterine sarcomas diagnosed using the World Health Organization classification system Hum Pathol 40 11 2009 1571 1585
11. R. Koivisto-Korander, R. Butzow, A.M. Koivisto, and A. Leminen Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: experience in Helsinki University Central Hospital 1990-2001 Gynecol Oncol 111 1 2008 74 81
12. K. Mayerhofer, A. Obermair, G. Windbichler, E. Petru, A. Kaider, L. Hefler, and et al. Leiomyosarcoma of the uterus: a clinicopathologic multicenter study of 71 cases Gynecol Oncol 74 2 1999 196 201
13. M.W. Jones, and H.J. Norris Clinicopathologic study of 28 uterine leiomyosarcomas with metastasis Int J Gynecol Pathol 14 3 1995 243 249
14. D.S. Kapp, J.Y. Shin, and J.K. Chan Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas: emphasis on impact of lymphadenectomy and oophorectomy Cancer 112 4 2008 820 830
15. E. D'Angelo, I. Espinosa, R. Ali, C.B. Gilks, M. Rijn, C.H. Lee, and et al. Uterine leiomyosarcomas: tumor size, mitotic index, and biomarkers Ki67, and Bcl-2 identify two groups with different prognosis Gynecol Oncol 121 2 2011 328 333
16. M.L. Hensley, N. Ishill, R. Soslow, J. Larkin, N. Abu-Rustum, P. Sabbatini, and et al. Adjuvant gemcitabine plus docetaxel for completely resected stages I-IV high grade uterine leiomyosarcoma: Results of a prospective study Gynecol Oncol 112 3 2009 563 567
17. M.P. Hardman, J.J. Roman, A.F. Burnett, and A.D. Santin Metastatic uterine leiomyosarcoma regression using an aromatase inhibitor Obstet Gynecol 110 2 Pt 2 2007 518 520
18. B.J. Monk, J.A. Blessing, D.G. Street, C.Y. Muller, J.J. Burke, and M.L. Hensley A phase II evaluation of trabectedin in the treatment of advanced, persistent, or recurrent uterine leiomyosarcoma: A gynecologic oncology group study Gynecol Oncol 124 1 2012 48 52
19. K.L. Chang, G.S. Crabtree, S.K. Lim-Tan, R.L. Kempson, and M.R. Hendrickson Primary uterine endometrial stromal neoplasms. A clinicopathologic study of 117 cases Am J Surg Pathol 14 5 1990 415 438
20. P. Baker, and E. Oliva Endometrial stromal tumours of the uterus: a practical approach using conventional morphology and ancillary techniques J Clin Pathol 60 3 2007 235 243
21. M.R. Nucci, D. Harburger, J. Koontz, P. Dal Cin, and J. Sklar Molecular analysis of the JAZF1-JJAZ1 gene fusion by RT-PCR and fluorescence in situ hybridization in endometrial stromal neoplasms Am J Surg Pathol 31 1 2007 65 70
22. J.K. Chan, N.M. Kawar, J.Y. Shin, K. Osann, L.M. Chen, C.B. Powell, and et al. Endometrial stromal sarcoma: a population-based analysis Br J Cancer 99 8 2008 1210 1215
23. J.P. Spano, J.C. Soria, M. Kambouchner, S. Piperno-Neuman, F. Morin, J.F. Morere, and et al. Long-term survival of patients given hormonal therapy for metastatic endometrial stromal sarcoma Med Oncol 20 1 2003 87 93
24. S. Kurihara, Y. Oda, Y. Ohishi, A. Iwasa, T. Takahira, E. Kaneki, and et al. Endometrial stromal sarcomas and related high-grade sarcomas: immunohistochemical and molecular genetic study of 31 cases Am J Surg Pathol 32 8 2008 1228 1238
25. C.H. Lee, A. Marino-Enriquez, W. Ou, M. Zhu, R.H. Ali, S. Chiang, and et al. The clinicopathologic features of YWHAE-FAM22 endometrial stromal sarcomas: a histologically high-grade and clinically aggressive tumor Am J Surg Pathol 36 5 2012 641 653
26. E.J. Tanner, K. Garg, M.M. Leitao Jr, R.A. Soslow, and M.L. Hensley High grade undifferentiated uterine sarcoma: surgery, treatment, and survival outcomes Gynecol Oncol 127 1 2012 27 31
27. P.B. Clement, and R.E. Scully Mullerian adenosarcoma of the uterus: a clinicopathologic analysis of 100 cases with a review of the literature Hum Pathol 21 4 1990 363 381
28. A. Gallardo, and J. Prat Mullerian adenosarcoma: A clinicopathologic and immunohistochemical study of 55 cases challenging the existence of adenofibroma Am J Surg Pathol 33 2 2009 278 288
29. S.E. Ferguson, C. Tornos, A. Hummer, R.R. Barakat, and R.A. Soslow Prognostic features of surgical stage I uterine carcinosarcoma Am J Surg Pathol 31 11 2007 1653 1661
30. S.D. Yamada, R.A. Burger, W.R. Brewster, D. Anton, M.F. Kohler, and B.J. Monk Pathologic variables and adjuvant therapy as predictors of recurrence and survival for patients with surgically evaluated carcinosarcoma of the uterus Cancer 88 12 2000 2782 2786
31. E. George, T.J. Lillemoe, L.B. Twiggs, and T. Perrone Malignant mixed mullerian tumor versus high-grade endometrial carcinoma and aggressive variants of endometrial carcinoma: a comparative analysis of survival Int J Gynecol Pathol 14 1 1995 39 44
32. R.A. Soslow, J.P. Bissonnette, A. Wilton, S.E. Ferguson, K.M. Alektiar, L.R. Duska, and et al. Clinicopathologic analysis of 187 high-grade endometrial carcinomas of different histologic subtypes: similar outcomes belie distinctive biologic differences Am J Surg Pathol 31 7 2007 979 987
33. K.M. Alektiar, A. McKee, O. Lin, E. Venkatraman, M.J. Zelefsky, B. McKee, and et al. Is there a difference in outcome between stage I-II endometrial cancer of papillary serous/clear cell and endometrioid FIGO Grade 3 cancer? Int J Radiat Oncol Biol Phys 54 1 2002 79 85
34. M. Callister, L.M. Ramondetta, A. Jhingran, T.W. Burke, and P.J. Eifel Malignant mixed Müllerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome Int J Radiat Oncol Biol Phys 58 3 2004 786 796
35. N.S. Reed, C. Mangioni, H. Malmström, G. Scarfone, A. Poveda, S. Pecorelli, and et al. Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: An European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874) Eur J Cancer 44 6 2008 808 818